(in Japanese)

  
     <Japanese>  ≫≫Oct.3 (Tue)
≫≫Oct.4 (Wed)
≫≫Oct.5 (Thu)		   （2017.9.20）  
Oct.2(Mon) Oct.2(Mon) Oct.2(Mon)
Oct
2
Mon		 Time 2F 1F 5F 3F 4F
Fukuju(144) Togen(144) Hall Small Hall(250) 303(48) Training Room(84) 401(63) 402(30) 403(30) 406(30) 407(36)
            <Tutorial>          
 
[1st day] Oct.3(Tue) [1st day] Oct.3(Tue) [1st day] Oct.3(Tue)
Oct
3
Tue


1st
day		 Time 2F 1F 5F 3F 4F
Fukuju(144) Togen(144) Hall Small Hall(250) 303(48) Training Room(84) 401(63) 402(30) 403(30) 406(30) 407(36)
10:00-10:20 <Opening Remarks>                  
10:20-11:00 <Conference Chairperson>
Chair: Shinichi Katakura(DAIICHI SANKYO RD NOVARE CO., LTD.)
K-01 Katsuhisa Horimoto (AIST)
"IT-Booster by Using Omics Data in Drug Discovery and Development: Exodus from Gambling World"		                  
11:00-12:00 <Plenary Lecture> "Data-Driven Research in Pharmaceutical Company"
Chair: Katsuhisa Horimoto (AIST)
K-02 Keiichi Masuya (PeptiDream Inc.)
"Importance of in silico in drug discovery research"		                 　
12:00-13:30         <Luncheon Seminar>
LS-01
MOLSIS Inc.
 <Luncheon Seminar>
LS-02
Patcore, Inc.
  CBI2018 Committee    
13:30-14:00   Poster Session                
14:00-15:30 <Invited Talk> "Data-Driven Research in Pharmaceutical Company"
Chair: Katsuhisa Horimoto (AIST)
I-01 Tatsuya Andou (Takeda Pharmaceutical Co., Ltd.)
"Strategic Usage of Genome Data to Open New Era of Drug Discovery and Development"
I-02 Kazuto Yamazaki (Sumitomo Dainippon Pharma Co., Ltd.)
"A data-driven innovation challenge in first-in-class drug discovery"
I-03 Naoki Kiyosawa (DAIICHI SANKYO COMPANY, LIMITED)
"Patient data-intensive translational research in a pharmaceutical company"
  <Public Lecture>
"To strengthen physical and mental health"
Noriko Osumi(Tohoku University)
"Lipid in Health of Brain & Mind"
Kiyoko Kaneko(Teikyo University)
"What is a point for controlling serum uric acid and gouty attack?"
Junko Umezu(Minano-machi office, Saitama Pref.)
"Let's aim at the wonderful silver generation by sodium restriction and exercise"
Kiyoshi Koubuchi(General Incorporated association of Japanese Houses To The 22nd Century)
"About Air Quality and Health"
Toshihisa Ishikawa(NGO Personalized Medicine & Healthcare)
""Healthcare" is a key factor to activate local cities in Japan"
  <Focused Session>
FS-01
Computational toxicology and artificial intelligence (1)： Basics of artificial intelligence in computational toxicology. Past, present and future 		<Focused Session>
FS-02
Oral Presentation
(molecular recognition and molecular modeling)		 <Sponsor's workshop>
Biomodeling Research Co., Ltd.		   <Focused Session>
FS-03
Oral Presentation		 <Focused Session>
FS-04
Advanced Measurement and Analysis
15:30-16:00   Poster Session              
16:00-17:30 <Sponsored Session>
SS-01
Dotmatics Limited		     <Focused Session>
 <Focused Session>
FS-07
About principles of OMICs -for the future of drug design-		       <Focused Session>
FS-04
Advanced Measurement and Analysis
17:30-19:30 17:30-18:00 CBI general meeting Poster Session                
 »» page top
 		 >> page top 
[2nd day] Oct.4(Wed) [2nd day] Oct.4(Wed) [2nd day] Oct.4(Wed)
Oct
4
Wed


2nd
day		 Time 2F 1F 5F 3F 4F
Fukuju(144) Togen(144) Hall Small Hall 303(48) Training Room(84) 401 402 403 406 407
10:00-12:00 <Plenary Lecture> "Artificial Intelligence and Big Data"
Chair: Akihiko Konagaya (Tokyo Institute of Technology)
K-03 Masashi Sugiyama (RIKEN/The Univ. of Tokyo)
"Introduction to RIKEN Center for Advanced Intelligence Project"
K-04 Jun-ichi Tsujii（AIST）
"AI for Science and Engineering : How to accelerate scientific research and technology development by AI"
K-05 Toshio Yanagida (NICT)
"Decoding brain information from human brain activities"
                 
12:00-13:30         <Luncheon Seminar>
LS-03
HULINKS Inc.
 <Luncheon Seminar>
LS-04
Dotmatics Limited
   CBIJ Editing Committee    
13:30-14:30   Poster Session                
14:30-16:00 <Invited Talk>"Artificial Intelligence and Big Data"
Chair: Takatsugu Hirokawa (AIST)
I-04 Daisuke Okanohara (Preferred Networks Inc. )
"Deep Learning in Drug Development: From discovery to creation"
I-05 Koji Tsuda (The Univ. of Tokyo)
"Discovery of Functional Molecules and Materials by Artificial Intelligence Techniques"
I-06 Jun Kikuchi (RIKEN)
"Data science and machine learning analysis of foods and metabolism"
  <Open symposium >
(FMODD)FMO Drug Design Consortium / KBDD (K supercomputer-based drug discovery project by Biogrid pharma consortium) 		<Focused Session>
FS-12
Participatory Healthcare and Rapid Learning-1		 <Focused Session>
FS-08
Computational toxicology and related topics		 <Focused Session>
FS-09
The 5th Working Group Meeting on Omics-based Analysis		     <Focused Session>
FS-10
Oral Presentation
(Information and computing approach for drug design and ADMET study)		 <Focused Session>
FS-11
Frontier of the research on infectious diseases using computational chemistry
16:00-16:30   Poster Session              
16:30-18:00 <Sponsored Session>
SS-02
OPT Holding Inc., DataScienceLab		   <Focused Session>
FS-12
Participatory Healthcare and Rapid Learning-2		 <Focused Session>
FS-13
Computational toxicology and “Lead across” This Focused Session will be held in collaboration with CBI (Chem-Bio Informatics Society) and JSAAE (Japanese Society for Alternatives to Animal Experiments) 		<Focused Session>
FS-14
Oral Presentation
(Bioinformatis and Medical Application)
  <Focused Session>
  
18:00-19:00   Poster Session           CBI Poster Selection Meeting    
19:00-21:00 Banquet (2F "Zuiun")                  
 >> page top
 		 >> page top 
[3rd day] Oct.5(Thu) [3rd day] Oct.5(Thu) [3rd day] Oct.5(Thu)
Oct
5
Thu


3rd
day		 Time 2F 1F 5F 3F 4F
Fukuju(144) Togen(144) Hall Small Hall 303(48) Training Room(84) 401 402 403 406 407
10:00-12:00 <Plenary Lecture> "Technology for Academia Drug Discovery and its Application"
Chair: Yasushi Okuno (Kyoto University)
K-06 Naoki Goshima（AIST）
"Utilization of human in vitro proteome in drug discovery"
K-07 Hiroki Ueda (The Univ. of Tokyo)
"Whole-body and Whole-brain Clearing and Imaging towards Organism-level Systems Biology"
K-08 Yuji Sugita (RIKEN)
"Simulation for drug discovery including protein dynamics and cellular environments"
                　
12:00-13:30         <Luncheon Seminar>
LS-05
RIKEN / Japan Pharmaceutical Manufacturers Association
<Luncheon Seminar>
LS-06
OpenEye Japan Co., Ltd.
      　
13:30-15:00 <Invited Talk> "Technology for Academia Drug Discovery and its Application"
Chair: Shigenori Tanaka (Kobe University)
I-07 Tsukasa Ishihara (AIST)
"Integration of Automated Design and Synthesis Boosts Drug Discovery"
I-08 Yoshihiro Yamanishi (Kyushu University)
"In silico drug discovery by machine learning and data-driven drug repositioning"
I-09 Hiraku Oshima (RIKEN)
"Development of ligand-binding free energy calculation including structural flexibility of protein"
 
  <Focused Session>
FS-15
Computational toxicology and artificial intelligence (2): AI-Substances Hazardous Integrated Prediction System (AI-SHIPS) Project		 <Tutorial>


     <Focused Session>
FS-16
Individualized medicine for cancer therapy		 <Focused Session>
FS-17
A new era of zebrafish research: towards establishment of disease models and application to drug screening
15:00-15:30 Poster Award       　 　 　
15:30-17:00 <Sponsored Session>
SS-03
NVIDIA Japan
  <Focused Session>
FS-18
Platforms for ADME/Tox prediction Introduction to AMED project "Construction of drug discovery informatics system"
    
<Focused Session>
17:00-17:15 Closing Remarks                  
>> page top >> page top
> <
> <